Q4 Top Earnings Performers: Brookdale (NYSE:BKD) and Other Senior Health, Home Health, and Hospice Shares

Q4 Review: Senior Health, Home Health & Hospice Sector Performance

With the fourth quarter earnings season wrapping up, it's an opportune moment to evaluate which companies in the senior health, home health, and hospice sectors excelled and which lagged behind, including Brookdale (NYSE:BKD) and its industry counterparts.

Industry Overview

Organizations in the senior health, home care, and hospice fields deliver vital support to elderly individuals and those facing chronic or terminal illnesses. Their business models often rely on long-term relationships with patients and families, resulting in steady, recurring income streams. However, these sectors face challenges due to their dependence on a large workforce, making them susceptible to rising labor expenses and staffing shortages. Profit margins are further pressured by reimbursement rates set by Medicare, Medicaid, and private insurers.

Looking forward, demographic trends such as an aging population and a rise in chronic diseases are expected to drive demand. There is also a growing preference for personalized care delivered at home. Technological advancements, including telehealth and remote monitoring, are poised to improve operational efficiency and patient outcomes. Nevertheless, persistent issues like workforce shortages, wage increases, and regulatory uncertainties around reimbursements remain obstacles. Embracing digital solutions and technology-driven care will be essential for sustained growth.

Q4 Earnings Snapshot

Among the seven senior health, home health, and hospice companies tracked, the group collectively posted a modest quarter, with revenues surpassing analyst forecasts by 1.1%.

Despite these results, share prices have struggled, with the group experiencing an average decline of 7.4% since the latest earnings announcements.

Brookdale (NYSE:BKD) Performance

Brookdale Senior Living operates more than 650 communities across 41 states, serving around 59,000 residents. Its offerings include independent living, assisted living, memory care, and continuing care retirement communities throughout the United States.

For the quarter, Brookdale reported $754.1 million in revenue, representing a 3.4% decrease compared to the previous year and falling short of analyst projections by 1.7%. The company’s full-year EBITDA guidance was in line with expectations, but overall, this was a slower period for Brookdale.

Nick Stengle, Brookdale’s CEO, commented, “Our fourth quarter results continued the positive momentum seen throughout 2025, positioning Brookdale to benefit from rising industry demand amid limited supply growth.”

Brookdale Total Revenue

Brookdale experienced the weakest revenue growth among its peers. Since releasing its earnings, the stock has dropped 9.5% and is currently trading at $15.00.

Top Q4 Performer: BrightSpring Health Services (NASDAQ:BTSG)

Established in 1974, BrightSpring Health Services provides a range of services including home health care, hospice, neuro-rehabilitation, and pharmacy solutions.

BrightSpring posted $3.55 billion in revenue for the quarter, marking a 16.3% year-over-year increase and surpassing analyst expectations by 5%. The company not only exceeded revenue forecasts but also delivered full-year EBITDA guidance above analyst estimates, signaling a robust quarter.

BrightSpring Health Services Total Revenue

BrightSpring achieved the largest outperformance relative to analyst projections among its peers. The market responded positively, with shares rising 1.2% since the earnings release, now trading at $40.60.

Lowest Q4 Performer: Chemed (NYSE:CHE)

Chemed operates two distinct businesses: VITAS, which specializes in hospice care for terminally ill patients, and Roto-Rooter, which provides plumbing and water restoration services.

During the quarter, Chemed reported $639.3 million in revenue, unchanged from the prior year and missing analyst expectations by 3%. The company also fell short of full-year EPS and revenue guidance, making for a disappointing quarter.

Chemed’s results were the weakest compared to analyst estimates among the group. The stock has declined 9% since the earnings announcement and is currently priced at $424.69.

AdaptHealth (NASDAQ:AHCO)

AdaptHealth operates a network of roughly 680 locations, providing home medical equipment, supplies, and services to patients with chronic health conditions such as sleep apnea, diabetes, and respiratory illnesses across all 50 states.

The company reported $846.3 million in revenue for the quarter, a 1.2% decrease year over year, but still exceeded analyst expectations by 2.1%. While AdaptHealth outperformed on revenue, it missed significantly on EPS estimates, resulting in a mixed quarter overall.

AdaptHealth raised its full-year guidance more than any of its peers. Since the earnings release, shares have fallen 8.6% and are now trading at $9.41.

Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare serves about 66,000 clients in 22 states, focusing on individuals eligible for both Medicare and Medicaid. The company offers in-home personal care, hospice, and home health services to seniors, those with chronic illnesses, and people with disabilities.

For the quarter, Addus HomeCare reported $373.1 million in revenue, a 25.6% increase from the previous year, matching analyst expectations. However, performance in other areas was mixed.

The company’s stock has dropped 12.1% since the earnings report and is currently valued at $103.43.

Looking for High-Quality Investment Opportunities?

Interested in companies with strong fundamentals? These businesses are well-positioned for growth, regardless of political or economic shifts.

The StockStory analyst team, comprised of experienced professional investors, leverages quantitative analysis and automation to deliver timely, high-quality market insights.